Adaptogens for Stress: What the Evidence Actually Shows

See your cortisol and stress markers

Measure cortisol, DHEA-S, thyroid, and metabolic markers before and after your adaptogen trial

• CLIA-certified labs
• HIPAA compliant
• Personalized protocols

Book your test

What are adaptogens?

Adaptogens are plant and mushroom extracts described as stress-response modifiers that increase nonspecific resistance to stress, helping the body adapt to a demand rather than blunting the nervous system. Adaptogens for stress are sold as adaptogenic herbs, stress-modulating botanicals, and herbal stress support, and the defining feature of the category is that these extracts act on many targets at once instead of through a single receptor.

That label is older than the evidence behind it. The classical adaptogens, Panax ginseng, Eleutherococcus senticosus, Rhodiola rosea, and Schisandra chinensis were named in Soviet-era research decades before modern trial standards existed. So "adaptogen" describes a proposed category of action, not a proven drug class, and the word on a label tells you nothing about whether that particular product has been tested.

The three criteria an herb must meet

The classical definition sets three bars an herb has to clear:

• It raises nonspecific resistance to a wide range of stressors, not to one specific insult.
• It has a normalizing effect, pulling a disturbed system back toward baseline rather than pushing hard in one direction.
• It is non-toxic at normal doses.

Those criteria are pharmacological conventions, not regulatory or FDA definitions, and the proposed mechanism behind them is network-level and still incompletely characterized.

How adaptogens act on the stress response

Adaptogens are proposed to work on the stress-response machinery itself, acting on the HPA axis, cortisol, nitric oxide, and stress-activated protein kinase signaling rather than sedating the nervous system the way an anxiolytic does. That distinction matters: the proposed target is regulation, not suppression.

What that has actually produced in clinical work is more modest than the marketing suggests. The consistent human signal is an anti-fatigue effect that increases mental work capacity against a background of stress and fatigue, which is a performance-under-load observation rather than management of anxiety or a mood condition.

Nor do adaptogens reliably push cortisol down. Six weeks of Panax ginseng in endurance athletes changed neither testosterone nor cortisol nor their ratio, while in the eleuthero group the testosterone-to-cortisol ratio fell by 28.7%, driven mainly by a trend toward increased cortisol, the opposite direction to the expected effect. Direction of effect appears to depend on the person and the stress load they are already carrying.

The HPA axis and cortisol

The hypothalamic-pituitary-adrenal axis is the hormone loop that converts a perceived threat into a cortisol release from the adrenal glands. Cortisol also runs on a daily rhythm, set by the suprachiasmatic nucleus, peaking shortly after waking and falling across the day. One cortisol number is therefore inseparable from the clock time it was drawn.

Chronic stress is a physiological state, not just a mood. Sustained HPA activation and cortisol dysregulation carry consequences across neurological, immune, and metabolic systems. The scale is not trivial either: across six prospective cohorts totaling 118,696 people, high versus low perceived stress carried a 1.27 risk ratio for incident coronary heart disease. That is a reason to take stress seriously, not evidence that any herb changes cardiac risk.

What the evidence actually shows for stress

The human evidence for adaptogens for stress is real but small, short, and inconsistent, built mostly from randomized trials running a few weeks to a few months. The flagship result carries its own warning label: across 12 RCTs in 1,002 participants, ashwagandha significantly reduced anxiety and stress versus placebo, with heterogeneity of 93.8% and 83.1% respectively and certainty of evidence rated low.

Here is the finding most consumer pages skip: a marker can move while the person feels no different. Pooling seven RCTs on cortisol and six on perceived stress at doses of at least 250 mg/day, ashwagandha lowered cortisol by 1.16 µg/dL but changed Perceived Stress Scale scores not at all. Meta-analyses genuinely disagree on the subjective outcome, which is why the numbers matter more than a flat claim that an herb "works."

None of this is a treatment plan. No adaptogen is approved as a therapy for a stress or anxiety condition, and the picture at consumer-guidance level remains that some preparations may help with stress and sleep while the evidence on anxiety is unclear. Clinical care for a mood or anxiety disorder is a separate question from a supplement decision.

Join 150,000+ others building better health

Get the science behind better health, every week.

SubscribeSigning up...

By clicking “Subscribe” you agree to our Terms of Service and Privacy Policy.

Thanks for signing up!

Check your inbox — your first issue is on the way. We send clinically reviewed health science, never spam.

The best-studied adaptogens for stress

Ashwagandha carries the most human stress data of any adaptogen, pooled across 12 randomized trials, rhodiola is positioned around mental fatigue and work capacity, and the rest sit on fatigue, performance, or traditional-use evidence rather than stress trials. Each herb entry keeps the same order: what it is, what the stress evidence shows, the studied dose, timing, and who should avoid it.

| Herb | Primary studied use | Typical studied dose range | Best time of day | Key cautions | | --- | --- | --- | --- | --- | | Ashwagandha | Stress, anxiety, and sleep scores | 300-600 mg/day of standardized extract | Evening | Pregnancy, thyroid and autoimmune conditions, liver injury reports | | Rhodiola rosea | Mental and physical fatigue, work capacity | 200 mg twice daily for four weeks | Morning or early afternoon | Insomnia, dizziness, headache, dry mouth, losartan interaction | | Holy basil (tulsi) | Broad metabolic, immune, and neurocognitive outcomes | not established across the human literature | Not established | Dose form and target population unclear | | Reishi | Fatigue in a clinical population | 1,800 mg three times daily for eight weeks | With meals | No placebo-controlled stress trial | | Panax ginseng | Fatigue and mental energy | 1-2 g/day of extract for four weeks | Morning | Insomnia, blood sugar, clotting, autoimmune disease | | Eleuthero | Symptoms of asthenia such as fatigue | dose varies by preparation form | Morning | May raise cortisol under athletic load | | Schisandra | Physical working capacity, stress resistance | no modern human stress-trial dose | Not established | Modern controlled data lacking | | Cordyceps | Exercise tolerance | 4 g/day of a mushroom blend | Morning | Not a stress or cortisol agent | | Astragalus | Traditional tonic use | dose varies by preparation form | Not established | No stress-efficacy evidence |

Ashwagandha

Ashwagandha is the adaptogen with the most human stress and sleep data, and also the one where the label matters most. Extracts differ by plant part and potency: root versus root-and-leaf preparations, standardized by withanolide content, which is why two products at the same milligram dose are not interchangeable.

The numbers are decent and the disagreement is real. Across nine RCTs in 558 participants, ashwagandha produced pooled improvements of 4.72 points on the Perceived Stress Scale and 2.58 units on serum cortisol, and five RCTs in 400 participants found a small but significant sleep improvement, strongest at 600 mg/day or more for at least eight weeks. Set against that, the pooled analysis showing no change in perceived stress means the honest summary is a measurable cortisol effect and an uncertain felt one.

For dosing, 300-600 mg/day has the dose-response support for stress, and evening dosing fits the sleep-weighted evidence. Ashwagandha should be avoided in pregnancy and by people with thyroid or autoimmune conditions. Liver injury reports belong to this herb too.

Rhodiola rosea

Rhodiola is the adaptogen people reach for when the problem is mental fatigue and burnout rather than sleep, with clinical work covering life-stress symptoms, cognitive function, and mental performance. Much of the supporting evidence there is pre-clinical, and the review authors work for a botanical-extract company, so it is a starting point rather than a verdict.

The best-known positive human result comes with a large asterisk: 101 subjects taking 200 mg twice daily for four weeks reported improvements in perceived stress and fatigue with good tolerability, in a study that was open-label with no placebo group. The systematic review is blunter. Across 11 controlled trials, only 2 of 6 physical-fatigue and 3 of 5 mental-fatigue trials were positive, and every included study carried high or unclear risk of bias.

So: 200 mg twice daily is the studied range, taken in the morning or early afternoon given the insomnia signal. The honest verdict is that there is not yet enough evidence to say whether rhodiola is useful for any health purpose, with possible dizziness, headache, insomnia, and dry mouth, plus a reported interaction with losartan. Its tolerability profile is genuinely good, though: in a 12-week trial against sertraline, rhodiola produced smaller symptom improvement with significantly fewer adverse events, a comparison that belongs to a clinician's decision, not a supplement aisle one.

Holy basil (tulsi)

Holy basil, Ocimum sanctum, has more breadth of human data than most people expect and less precision. A systematic review of 24 human studies spanning metabolic, cardiovascular, immune, and neurocognitive outcomes found favorable results throughout, with no significant adverse events reported.

The catch is the dosing answer. Because dosage, dose form, and target populations remain unclear across that literature, there is no studied stress dose for tulsi the way there is for ashwagandha, and the outcomes measured were broad rather than stress-specific. That is why its row in the table stays qualitative.

Reishi

Reishi's strongest human evidence is a fatigue trial in a clinical population, not a stress trial, and the difference is not cosmetic. In 132 patients taking 1,800 mg of a polysaccharide extract three times daily for eight weeks, sense of fatigue fell 28.3% from baseline versus 20.1% on placebo, with 51.6% rated more than minimally improved compared with 24.6% on placebo.

Those numbers should not be read across to stress or cortisol. No comparable placebo-controlled stress trial exists for reishi, so the most that can be said is that it may support recovery from fatigue in the studied setting.

Panax ginseng and eleuthero

Ginseng's headline trial missed its primary endpoint, which is worth knowing before buying anything. In 90 adults with idiopathic chronic fatigue taking 1 g or 2 g/day for four weeks, total fatigue score did not differ significantly from placebo, although the mental-fatigue subscore improved and the 2 g/day group's visual analogue score fell from 7.3 to 4.4. That supports a hedged energy-and-fatigue positioning, not a cortisol claim.

Eleuthero's standing rests on history and regulators rather than trial data: it entered the USSR pharmacopeia in 1962, and the European Medicines Agency recommends it for symptoms of asthenia such as fatigue and weakness. Ginseng carries specific cautions, since it may worsen autoimmune disorders and interfere with blood clotting, can lower blood sugar, and lists insomnia as its most common side effect.

Schisandra, astragalus, and cordyceps

These three round out the classical category and share one verdict: adaptogen standing, no modern placebo-controlled human stress trial. Schisandra was adopted into the USSR National Pharmacopoeia on the strength of animal and early human work on physical working capacity and stress resistance, and nothing since has replaced that with contemporary controlled data.

Cordyceps stays in its own lane. In 28 adults, only 10 of whom continued to three weeks, 4 g/day of a Cordyceps militaris-containing blend showed no significant effect at one week and improved VO2max by three weeks. That is exercise-tolerance evidence and must not be imported into a stress or cortisol claim. Astragalus appears in clinician adaptogen references for its traditional uses and preparation forms, with no stress-efficacy claim attached.

Adaptogen dosing, timing and forms

Studied doses are herb-specific and narrower than product labels suggest: 300-600 mg/day of standardized ashwagandha extract for stress, 200 mg twice daily of rhodiola, and 1-2 g/day of ginseng extract, in trials that ran four to twelve weeks rather than days.

Timeframe is the part most people get wrong. An eight-week double-blind placebo-controlled dose-ranging study in adults with self-reported high stress, 131 enrolled and 98 analyzed, found dose-dependent reductions in Perceived Stress Scale scores across 125, 250, and 500 mg/day, including at the low 125 mg/day dose. Expect to judge an adaptogen at four to eight weeks, not the next morning.

Form changes what a dose means:

• Standardized capsule extract: the form used in most trials, and the only one where a milligram figure maps to what was studied.
• Tincture: concentration varies by preparation, with dose given per preparation form rather than per herb.
• Dried root powder: bulkier and less consistent than an extract at the same stated weight.
• Tea: the lowest and least predictable delivery, better for ritual than for matching a trial dose.

Standardization is what makes those numbers usable at all, since root versus root-and-leaf extracts and withanolide percentage determine what a milligram actually delivers.

Timing follows the evidence rather than folklore. Ashwagandha belongs in the evening because its supporting data is weighted toward sleep quality; rhodiola belongs earlier in the day because insomnia is among its reported side effects. Any personal dosing decision is one to make with a clinician.

Adaptogens vs. other stress supplements

Adaptogens are not the only supplements studied for stress, and the closest alternatives act faster, work by different mechanisms, and rest on evidence that is honestly no stronger.

| Option | What the human evidence shows | Typical studied dose | How quickly it acts | Main caveat | | --- | --- | --- | --- | --- | | Ashwagandha | Cortisol down 1.16 µg/dL, perceived stress unchanged | 300-600 mg/day | 4-8 weeks | Meta-analyses disagree on the felt effect | | Rhodiola | 3 of 5 mental-fatigue trials positive | 200 mg twice daily | ~4 weeks | All trials at high or unclear risk of bias | | L-theanine | Improved depression, trait-anxiety, and sleep scores in 30 adults | 200 mg/day | 4 weeks | Small crossover trial in healthy adults | | Magnesium | Suggestive reduction in subjective anxiety | Varies by salt and study | Weeks | Low-quality evidence, mainly in susceptible groups |

None of these substitutes for the inputs that move stress physiology most, which are sleep, activity, and the load you are carrying. Which bottle you choose matters far less than whether the underlying stressor gets addressed.

Safety, side effects and drug interactions

Adaptogens can interact with blood pressure, diabetes, thyroid, sedative, and antidepressant medications. Ashwagandha carries documented interactions with thyroid hormone, immunosuppressant, and sedative medications, while Asian ginseng may lower blood sugar and interfere with blood clotting.

Then there is the harm consumer pages leave out entirely. Five adjudicated cases of liver injury have been attributed to ashwagandha-containing supplements, with jaundice and cholestatic injury patterns, and the published cases, their latency, and their outcomes are documented. Practically: new jaundice, dark urine, or right-upper-quadrant pain after starting an adaptogen is a reason to stop and get clinical review, not to wait it out.

The medication classes that warrant a conversation first:

• Thyroid hormone
• Sedatives and benzodiazepines
• Immunosuppressants
• Diabetes medications
• Anticoagulants and antiplatelets
• Antihypertensives

Quality is its own risk. Manufacturers, not the FDA, are responsible for evaluating supplement safety and labeling before marketing, and DNA authentication of 5,957 commercial herbal products across 37 countries found 27% were adulterated. Third-party-tested, standardized extracts are the sensible floor.

Who should avoid adaptogens

Some people should skip adaptogens or clear them first:

• Anyone pregnant or breastfeeding
• Anyone scheduled for surgery
• Anyone with an autoimmune or thyroid condition
• Anyone taking the medication classes listed above

The thyroid caution is measurable rather than theoretical. In 50 adults with TSH between 4.5 and 10 µIU/L, 600 mg/day of ashwagandha for eight weeks significantly shifted TSH, T3, and T4 versus placebo. That cuts both ways: an herb strong enough to move thyroid hormones is an herb that can disrupt thyroid management.

Some symptoms call for a clinician rather than a supplement. Persistent low mood, panic symptoms, unexplained weight change, new palpitations, or exhaustion that does not improve with rest all warrant evaluation, and the standing advice is to talk with a health care provider before starting anything in this category.

Biomarkers that show whether stress support is working

The case for measuring anything is that the marker and the feeling can move separately: in one pooled analysis, cortisol fell significantly while perceived stress scores did not budge. Without a measurement, you are grading a supplement on how a given week happened to go.

The markers that reflect sustained stress physiology:

• Cortisol, whose daily curve is set by the suprachiasmatic nucleus and whose chronic dysregulation reaches neurological, immune, and metabolic systems.
• DHEA-S, the adrenal counterpart usually read alongside cortisol rather than on its own.
• Thyroid markers, which matter here because ashwagandha itself measurably shifts TSH, T3, and T4.
• Glucose and HbA1c, the metabolic readout of stress physiology that has been running a long time.

Interpretation rules keep this honest. A single cortisol value is a snapshot, and the time of day the sample is drawn shapes the number. What is actually informative is the same markers measured before and after a defined trial period, read next to a subjective measure you tracked the whole way.

How to build adaptogens into a stress plan

A supplement trial is only interpretable if you run one variable at a time and give it long enough to show something.

1. Capture baseline markers and a baseline subjective stress score before the first dose.
2. Clear the choice with a clinician if you take any interacting medication or have thyroid, autoimmune, or liver disease.
3. Start one herb at a time, at a dose that has actually been studied.
4. Hold it for four to eight weeks, at least as long as the eight-week dose-ranging trial.
5. Track sleep quality and perceived stress throughout, not just at the end.
6. Reassess markers and symptoms together, and stop if neither has changed.

Worth saying plainly: no supplement outperforms addressing the stressor, the sleep debt, and the activity load underneath it. The evidence base for every herb here is short-duration, with short-term use of up to about three months being what has been studied and no conclusions available beyond it.

See your stress markers with a Superpower panel

Whether stress support is doing anything is a question you answer with measurements taken before and after, not with how a given week felt. Superpower makes it straightforward to see cortisol, DHEA-S, thyroid, and metabolic markers on the Superpower Blood Panel in a single draw, so a four-to-eight-week trial of adaptogens for stress ends with data instead of a guess.